Basics |
Akoya BioSciences, Inc.
|
IPO Date: |
April 12, 2021 |
Sector: |
Healthcare |
Industry: |
Medical Instruments and Supplies |
Market Cap: |
$63.34M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.27 | 3.40%
|
Avg Daily Range (30 D): |
$0.04 | 3.55%
|
Avg Daily Range (90 D): |
$0.06 | 4.00%
|
Institutional Daily Volume |
Avg Daily Volume: |
.18M |
Avg Daily Volume (30 D): |
.56M |
Avg Daily Volume (90 D): |
.38M |
Trade Size |
Avg Trade Size (Sh.): |
105 |
Avg Trade Size (Sh.) (30 D): |
230 |
Avg Trade Size (Sh.) (90 D): |
169 |
Institutional Trades |
Total Inst.Trades: |
105 |
Avg Inst. Trade: |
$1.98M |
Avg Inst. Trade (30 D): |
$.97M |
Avg Inst. Trade (90 D): |
$.97M |
Avg Inst. Trade Volume: |
.15M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$1.83M |
Avg Closing Trade (30 D): |
$.97M |
Avg Closing Trade (90 D): |
$.97M |
Avg Closing Volume: |
156.81K |
|
|
|
|
Financials |
|
TTM |
Q1 2025 |
Q4 2024 |
Basic EPS
|
$-.96
|
$-.32
|
$-.16
|
Diluted EPS
|
$-.96
|
$-.32
|
$-.16
|
Revenue
|
$ 79.96M
|
$ 16.64M
|
$ 21.34M
|
Gross Profit
|
$ 49.37M
|
$ 9.87M
|
$ 14.39M
|
Net Income / Loss
|
$ -47.53M
|
$ -15.65M
|
$ -8.2M
|
Operating Income / Loss
|
$ -38.56M
|
$ -13.41M
|
$ -5.71M
|
Cost of Revenue
|
$ 30.59M
|
$ 6.77M
|
$ 6.96M
|
Net Cash Flow
|
$ 7.31M
|
$ 8.58M
|
$ -.78M
|
PE Ratio
|
|
|
|
|